AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Redyx L 100mg Infusion

Prescription Icon
Prescription Required

Marketer

Reddy Pharmaceuticals

Salt Composition

Remdesivir (100mg)

Overview Redyx L 100mg Infusion

Infusion of Virox-100 (100mg) offers broad-spectrum antiviral action, indicated for hospitalized adults and children with severe, confirmed or suspected COVID-19. This medication accelerates recovery by reducing the body's viral burden. Virox-100 functions by inhibiting RNA-dependent RNA polymerase, a crucial enzyme for SARS-CoV-2 replication. Administered intravenously under medical supervision, it requires a doctor's prescription and adherence to the prescribed dosage and duration. Self-medication is strictly prohibited. Common adverse effects may include elevated blood glucose, anemia, fever, acute kidney injury, and increased transaminase levels. Report any allergic reactions or concerning side effects to your physician. Inform your doctor of pregnancy or breastfeeding. Use in elderly or pediatric patients warrants careful monitoring.

Primary Ingredients of Redyx L 100mg Infusion

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Redyx L 100mg Infusion

Managing the Coronavirus (COVID-19) infection

Major Benefits of Redyx L 100mg Infusion:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Redyx L 100mg Infusion:

  • Headache
  • Rash
  • Extravasation
  • Increased prothrombin time
  • Increased transaminase level in blood

How to use Redyx L 100mg Infusion:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Redyx L 100mg Infusion works:

Infusion Redyx L 100mg is a wide-ranging antiviral medication. Its mechanism involves blocking RNA polymerase, an RNA-dependent enzyme crucial for SARS-CoV-2 replication. This action consequently reduces the viral burden within the patient.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of combining alcohol with Redyx L 100mg Infusion is undetermined. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Redyx L 100mg Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Redyx L 100mg Infusion while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Redyx L 100mg Infusion's effect on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Redyx L 100mg Infusion to individuals with renal impairment. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Redyx L 100mg Infusion administration to individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Redyx L 100mg Infusion :

NA

Facts to Know About Redyx L 100mg Infusion

LabelValue
Chemical Category Amino acid alkyl esters
Developing Habits No.
Treatment Category Antimicrobial Agents

FAQs on Redyx L 100mg Infusion

COVID-19, caused by the novel SARS-CoV-2 virus, is a highly contagious respiratory illness. This newly identified virus primarily affects the lungs, causing symptoms such as fever, cough, and shortness of breath. Transmission occurs rapidly between individuals.
Redyx L 100mg Infusion, an antiviral medication, demonstrates promising results in managing severe COVID-19 in hospitalized patients during recent laboratory studies. While not yet approved for COVID-19 treatment, these studies indicate potentially faster recovery times compared to alternative therapies. However, its efficacy and safety in treating COVID-19 require further investigation through ongoing clinical trials.
The Food and Drug Administration (FDA), under the authority of the Food, Drug, and Cosmetic Act, issues Emergency Use Authorizations (EUAs) for medical products—medicines, vaccines, or devices—to combat serious public health threats like COVID-19. An EUA permits the use of such products before full approval, balancing potential benefits against known risks.
Redyx L 100mg Infusion is a hospital-only intravenous injection for children and adults with severe COVID-19. Severe COVID-19 is defined as SpO2 ≤94% on room air, or requiring supplemental oxygen, mechanical ventilation, or ECMO. Administered by a doctor only; self-administration is prohibited. Follow your doctor's instructions for optimal results.
Redyx L 100mg Infusion is now authorized for use in EUAs to treat hospitalized adults and children with severe COVID-19, specifically those experiencing critical respiratory distress. This authorization is based on observed faster recovery times.
Ongoing clinical trials are evaluating Redyx L 100mg Infusion. Preliminary findings indicate it inhibits SARS-CoV-2 replication, reducing viral load and potentially accelerating recovery from COVID-19.
Redyx L 100mg Infusion may cause anemia, fever, kidney damage, nausea, vomiting, chills, sweating, low blood pressure, and elevated liver enzymes. However, this list is not exhaustive, and further research is needed to fully understand its side effects. The efficacy and safety of Redyx L 100mg Infusion in treating COVID-19 are still under investigation; therefore, additional, unknown risks may exist.
Insufficient data exists to confirm the safety and efficacy of Redyx L 100mg Infusion for treating hospitalized adults and children with severe COVID-19. Use in these patients is permitted only after careful risk-benefit assessment. Ongoing clinical trials are evaluating its safety and efficacy.
Data on Redyx L 100mg Infusion's use in COVID-19 treatment is limited. Its safety and effectiveness in pregnant or breastfeeding individuals are unknown. If you're pregnant, breastfeeding, or planning a pregnancy, and test positive or are suspected of having COVID-19, consult your doctor. They will determine the best course of treatment for you.
Inform your doctor of all medical conditions, including kidney or liver problems, serious illnesses like heart disease or diabetes, and allergies, before receiving Redyx L 100mg Infusion. Disclose all medications—prescription, over-the-counter, vitamins, or herbal products—as Redyx L 100mg Infusion may interact with other drugs. Specifically mention any chloroquine phosphate or hydroxychloroquine sulfate medications. Finally, tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Redyx L 100mg Infusion is not indicated for Covid-19 prevention; its efficacy in this regard is unsupported by evidence.
The Drug Controller General of India (DCGI) has granted emergency authorization for Redyx L 100mg Infusion due to the pandemic. Its use is restricted to confirmed COVID-19 patients with a clinical indication; it is not approved for preventative use in suspected cases.
Redyx L 100mg Infusion
2,216
MRP 2,700
17% off